Public Profile

Sigma-Genosys LP

Sigma-Genosys LP, a leading player in the biotechnology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1997, the company has established itself as a pioneer in the development and supply of high-quality oligonucleotides and custom DNA synthesis services. Sigma-Genosys is renowned for its innovative approach to nucleic acid synthesis, offering unique products that cater to a diverse range of applications, including genomics, diagnostics, and therapeutics. With a commitment to quality and precision, the company has achieved significant milestones, positioning itself as a trusted partner for researchers and organisations in the life sciences industry. Its dedication to advancing genetic research has solidified Sigma-Genosys's reputation as a key contributor to scientific progress.

DitchCarbon Score

How does Sigma-Genosys LP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

32

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Sigma-Genosys LP's score of 32 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.

59%

Let us know if this data was useful to you

Sigma-Genosys LP's reported carbon emissions

Sigma-Genosys LP, headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. Without specific emissions figures or commitments, it is challenging to assess their carbon footprint or climate strategy. However, the absence of data may indicate an opportunity for the company to enhance transparency and set measurable climate goals in line with industry standards. As the global focus on sustainability intensifies, Sigma-Genosys LP may benefit from establishing clear emissions reduction initiatives to align with best practices in environmental responsibility.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sigma-Genosys LP's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Sigma-Genosys LP is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Sigma-Genosys LP is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers